Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $198.17 Analyst target: $195.57 Upside: -1.31%
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
See the full interactive analysis & chart →Informational only — not investment advice.